Indicar - Interdisciplinary Cancer Research

+++PUBLICATION NEWS+++
Our fellow Alessio Terenzi has published as co-author in Scientific Reports: “Biological activity of PtIV prodrugs triggered by riboflavin-mediated bioorthogonal photocatalysis”.
The new study is a joint effort between the group of Prof. Luca Salassa (Donostia International Physics Center) and the groups of Profs. Walter Berger and Bernhard K. Keppler (Research Platform “Translational Cancer Therapy Research”, University of Vienna and Medical University of Vienna). The study highlights the possibility of combining photocatalysis and Pt(IV) prodrugs in the treatment of cancer. Congratulations!!

Biological activity of PtIV prodrugs triggered by riboflavin-mediated bioorthogonal photocatalysis Article

+++PUBLICATION NEWS+++

The INDICAR Fellow Laura Cimatti published as last author in the Journal RNA Biology: “Organ-wide profiling in mouse reveals high editing levels of Filamin B mRNA in the musculoskeletal system”. Congratulations Laura! 💪👍

www.tandfonline.com

On the 7th of June the INDICAR Fellow Konstantinos Kiakos presented his video “Drugging Cancer” at Top Kino, together with participants of the CommunicationHub.
Last October Konstantinos enrolled the CommunicationHub 2017/18 programme “My research as video“, organized by Wissenstransfer. Konstantinos worked on his video under the guidance and support of experts from Okto.
“Drugging Cancer” aims at disseminating the INDICAR program and Konstantinos’ research and to raise awareness on the research performed to discover new cancer drugs.

Drugging Cancer CommunicationHub 2017/2018 - My research as video “Cancer is the second leading cause of mortality worldwide. Approximately 1 in 3 people will develop some f...